1,901 reports of this reaction
2.2% of all DIVALPROEX SODIUM reports
#6 most reported adverse reaction
FATIGUE is the #6 most commonly reported adverse reaction for DIVALPROEX SODIUM, manufactured by AbbVie Inc.. There are 1,901 FDA adverse event reports linking DIVALPROEX SODIUM to FATIGUE. This represents approximately 2.2% of all 87,440 adverse event reports for this drug.
Patients taking DIVALPROEX SODIUM who experience fatigue should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
FATIGUE is a less commonly reported adverse event for DIVALPROEX SODIUM, but still significant enough to appear in the safety profile.
In addition to fatigue, the following adverse reactions have been reported for DIVALPROEX SODIUM:
The following drugs have also been linked to fatigue in FDA adverse event reports:
FATIGUE has been reported as an adverse event in 1,901 FDA reports for DIVALPROEX SODIUM. This does not prove causation, but indicates an association observed in post-market surveillance data.
FATIGUE accounts for approximately 2.2% of all adverse event reports for DIVALPROEX SODIUM, making it a notable side effect.
If you experience fatigue while taking DIVALPROEX SODIUM, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.